カテゴリー： QYResearch, 世界, 医療/バイオ

世界の肛門疾患治療市場インサイト及び予測（医薬品、外科手術、その他）

◆英語タイトル：Global Anorectal Disorders Treatment Market Insights, Forecast to 2028
	◆商品コード：QY22JLX09219 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：126 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、肛門疾患治療のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に肛門疾患治療の世界市場のxxx％を占める「医薬品」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
肛門疾患治療の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの肛門疾患治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

肛門疾患治療のグローバル主要企業には、AKORN、Novartis、Mylan、GlaxoSmithKline、Ferndale Pharma Group、F. Hoffmann-La Roche、Pfizer、Takeda Pharmaceutical Company Limited、AstraZeneca、GlaxoSmithKline、Bristol-Myers Squibb Company、Eli Lilly and Company、Merck、Sun Pharmaceutical Industries、NATCO Pharma Limited、LUPIN、Teva Pharmaceutical Industries、Boehringer Ingelheim International、AbbVie、Allergan、Aboott、Bayerなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

肛門疾患治療市場は、種類と用途によって区分されます。世界の肛門疾患治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
医薬品、外科手術、その他

【用途別セグメント】
病院、専門クリニック、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 肛門疾患治療製品概要
- 種類別市場（医薬品、外科手術、その他）
- 用途別市場（病院、専門クリニック、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の肛門疾患治療販売量予測2017-2028
- 世界の肛門疾患治療売上予測2017-2028
- 肛門疾患治療の地域別販売量
- 肛門疾患治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別肛門疾患治療販売量
- 主要メーカー別肛門疾患治療売上
- 主要メーカー別肛門疾患治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（医薬品、外科手術、その他）
- 肛門疾患治療の種類別販売量
- 肛門疾患治療の種類別売上
- 肛門疾患治療の種類別価格
・用途別市場規模（病院、専門クリニック、その他）
- 肛門疾患治療の用途別販売量
- 肛門疾患治療の用途別売上
- 肛門疾患治療の用途別価格
・北米市場
- 北米の肛門疾患治療市場規模（種類別、用途別）
- 主要国別の肛門疾患治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの肛門疾患治療市場規模（種類別、用途別）
- 主要国別の肛門疾患治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の肛門疾患治療市場規模（種類別、用途別）
- 主要国別の肛門疾患治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の肛門疾患治療市場規模（種類別、用途別）
- 主要国別の肛門疾患治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの肛門疾患治療市場規模（種類別、用途別）
- 主要国別の肛門疾患治療市場規模（トルコ、サウジアラビア）
・企業情報
AKORN、Novartis、Mylan、GlaxoSmithKline、Ferndale Pharma Group、F. Hoffmann-La Roche、Pfizer、Takeda Pharmaceutical Company Limited、AstraZeneca、GlaxoSmithKline、Bristol-Myers Squibb Company、Eli Lilly and Company、Merck、Sun Pharmaceutical Industries、NATCO Pharma Limited、LUPIN、Teva Pharmaceutical Industries、Boehringer Ingelheim International、AbbVie、Allergan、Aboott、Bayer
・産業チェーン及び販売チャネル分析
- 肛門疾患治療の産業チェーン分析
- 肛門疾患治療の原材料
- 肛門疾患治療の生産プロセス
- 肛門疾患治療の販売及びマーケティング
- 肛門疾患治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 肛門疾患治療の産業動向
- 肛門疾患治療のマーケットドライバー
- 肛門疾患治療の課題
- 肛門疾患治療の阻害要因
・主な調査結果

Anorectal disorders are medical disorders that occur or develop in the rectum or the anal canal. Rectal bleeding, hemorrhoids, fissures, and polyps are the common causes of anorectal disorders. The anorectal disorders can lead to excessive pain, itching and swelling around the anus and rectum and cause discomfort.
Market Analysis and Insights: Global Anorectal Disorders Treatment Market
The global Anorectal Disorders Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Drugs accounting for % of the Anorectal Disorders Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Anorectal Disorders Treatment market size is valued at US$ million in 2021, while the North America and Europe Anorectal Disorders Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Anorectal Disorders Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anorectal Disorders Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anorectal Disorders Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anorectal Disorders Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anorectal Disorders Treatment market.
Global Anorectal Disorders Treatment Scope and Market Size
Anorectal Disorders Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Anorectal Disorders Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Drugs
Surgery
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Company
AKORN
Novartis
Mylan
GlaxoSmithKline
Ferndale Pharma Group
F. Hoffmann-La Roche
Pfizer
Takeda Pharmaceutical Company Limited
AstraZeneca
GlaxoSmithKline
Bristol-Myers Squibb Company
Eli Lilly and Company
Merck
Sun Pharmaceutical Industries
NATCO Pharma Limited
LUPIN
Teva Pharmaceutical Industries
Boehringer Ingelheim International
AbbVie
Allergan
Aboott
Bayer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anorectal Disorders Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Drugs
1.2.3 Surgery
1.2.4 Others
1.3 Market by Application
1.3.1 Global Anorectal Disorders Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anorectal Disorders Treatment Market Perspective (2017-2028)
2.2 Anorectal Disorders Treatment Growth Trends by Region
2.2.1 Anorectal Disorders Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anorectal Disorders Treatment Historic Market Size by Region (2017-2022)
2.2.3 Anorectal Disorders Treatment Forecasted Market Size by Region (2023-2028)
2.3 Anorectal Disorders Treatment Market Dynamics
2.3.1 Anorectal Disorders Treatment Industry Trends
2.3.2 Anorectal Disorders Treatment Market Drivers
2.3.3 Anorectal Disorders Treatment Market Challenges
2.3.4 Anorectal Disorders Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anorectal Disorders Treatment Players by Revenue
3.1.1 Global Top Anorectal Disorders Treatment Players by Revenue (2017-2022)
3.1.2 Global Anorectal Disorders Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Anorectal Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anorectal Disorders Treatment Revenue
3.4 Global Anorectal Disorders Treatment Market Concentration Ratio
3.4.1 Global Anorectal Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anorectal Disorders Treatment Revenue in 2021
3.5 Anorectal Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Anorectal Disorders Treatment Product Solution and Service
3.7 Date of Enter into Anorectal Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anorectal Disorders Treatment Breakdown Data by Type
4.1 Global Anorectal Disorders Treatment Historic Market Size by Type (2017-2022)
4.2 Global Anorectal Disorders Treatment Forecasted Market Size by Type (2023-2028)
5 Anorectal Disorders Treatment Breakdown Data by Application
5.1 Global Anorectal Disorders Treatment Historic Market Size by Application (2017-2022)
5.2 Global Anorectal Disorders Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anorectal Disorders Treatment Market Size (2017-2028)
6.2 North America Anorectal Disorders Treatment Market Size by Type
6.2.1 North America Anorectal Disorders Treatment Market Size by Type (2017-2022)
6.2.2 North America Anorectal Disorders Treatment Market Size by Type (2023-2028)
6.2.3 North America Anorectal Disorders Treatment Market Share by Type (2017-2028)
6.3 North America Anorectal Disorders Treatment Market Size by Application
6.3.1 North America Anorectal Disorders Treatment Market Size by Application (2017-2022)
6.3.2 North America Anorectal Disorders Treatment Market Size by Application (2023-2028)
6.3.3 North America Anorectal Disorders Treatment Market Share by Application (2017-2028)
6.4 North America Anorectal Disorders Treatment Market Size by Country
6.4.1 North America Anorectal Disorders Treatment Market Size by Country (2017-2022)
6.4.2 North America Anorectal Disorders Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anorectal Disorders Treatment Market Size (2017-2028)
7.2 Europe Anorectal Disorders Treatment Market Size by Type
7.2.1 Europe Anorectal Disorders Treatment Market Size by Type (2017-2022)
7.2.2 Europe Anorectal Disorders Treatment Market Size by Type (2023-2028)
7.2.3 Europe Anorectal Disorders Treatment Market Share by Type (2017-2028)
7.3 Europe Anorectal Disorders Treatment Market Size by Application
7.3.1 Europe Anorectal Disorders Treatment Market Size by Application (2017-2022)
7.3.2 Europe Anorectal Disorders Treatment Market Size by Application (2023-2028)
7.3.3 Europe Anorectal Disorders Treatment Market Share by Application (2017-2028)
7.4 Europe Anorectal Disorders Treatment Market Size by Country
7.4.1 Europe Anorectal Disorders Treatment Market Size by Country (2017-2022)
7.4.2 Europe Anorectal Disorders Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anorectal Disorders Treatment Market Size (2017-2028)
8.2 Asia-Pacific Anorectal Disorders Treatment Market Size by Type
8.2.1 Asia-Pacific Anorectal Disorders Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Anorectal Disorders Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Anorectal Disorders Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Anorectal Disorders Treatment Market Size by Application
8.3.1 Asia-Pacific Anorectal Disorders Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Anorectal Disorders Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Anorectal Disorders Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Anorectal Disorders Treatment Market Size by Region
8.4.1 Asia-Pacific Anorectal Disorders Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Anorectal Disorders Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anorectal Disorders Treatment Market Size (2017-2028)
9.2 Latin America Anorectal Disorders Treatment Market Size by Type
9.2.1 Latin America Anorectal Disorders Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Anorectal Disorders Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Anorectal Disorders Treatment Market Share by Type (2017-2028)
9.3 Latin America Anorectal Disorders Treatment Market Size by Application
9.3.1 Latin America Anorectal Disorders Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Anorectal Disorders Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Anorectal Disorders Treatment Market Share by Application (2017-2028)
9.4 Latin America Anorectal Disorders Treatment Market Size by Country
9.4.1 Latin America Anorectal Disorders Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Anorectal Disorders Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anorectal Disorders Treatment Market Size (2017-2028)
10.2 Middle East & Africa Anorectal Disorders Treatment Market Size by Type
10.2.1 Middle East & Africa Anorectal Disorders Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Anorectal Disorders Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Anorectal Disorders Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Anorectal Disorders Treatment Market Size by Application
10.3.1 Middle East & Africa Anorectal Disorders Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Anorectal Disorders Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Anorectal Disorders Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Anorectal Disorders Treatment Market Size by Country
10.4.1 Middle East & Africa Anorectal Disorders Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Anorectal Disorders Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AKORN
11.1.1 AKORN Company Details
11.1.2 AKORN Business Overview
11.1.3 AKORN Anorectal Disorders Treatment Introduction
11.1.4 AKORN Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.1.5 AKORN Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Anorectal Disorders Treatment Introduction
11.2.4 Novartis Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Anorectal Disorders Treatment Introduction
11.3.4 Mylan Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.3.5 Mylan Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Anorectal Disorders Treatment Introduction
11.4.4 GlaxoSmithKline Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Ferndale Pharma Group
11.5.1 Ferndale Pharma Group Company Details
11.5.2 Ferndale Pharma Group Business Overview
11.5.3 Ferndale Pharma Group Anorectal Disorders Treatment Introduction
11.5.4 Ferndale Pharma Group Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.5.5 Ferndale Pharma Group Recent Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Company Details
11.6.2 F. Hoffmann-La Roche Business Overview
11.6.3 F. Hoffmann-La Roche Anorectal Disorders Treatment Introduction
11.6.4 F. Hoffmann-La Roche Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.6.5 F. Hoffmann-La Roche Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Anorectal Disorders Treatment Introduction
11.7.4 Pfizer Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.7.5 Pfizer Recent Developments
11.8 Takeda Pharmaceutical Company Limited
11.8.1 Takeda Pharmaceutical Company Limited Company Details
11.8.2 Takeda Pharmaceutical Company Limited Business Overview
11.8.3 Takeda Pharmaceutical Company Limited Anorectal Disorders Treatment Introduction
11.8.4 Takeda Pharmaceutical Company Limited Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.8.5 Takeda Pharmaceutical Company Limited Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Anorectal Disorders Treatment Introduction
11.9.4 AstraZeneca Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.9.5 AstraZeneca Recent Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Anorectal Disorders Treatment Introduction
11.10.4 GlaxoSmithKline Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.10.5 GlaxoSmithKline Recent Developments
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Details
11.11.2 Bristol-Myers Squibb Company Business Overview
11.11.3 Bristol-Myers Squibb Company Anorectal Disorders Treatment Introduction
11.11.4 Bristol-Myers Squibb Company Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.11.5 Bristol-Myers Squibb Company Recent Developments
11.12 Eli Lilly and Company
11.12.1 Eli Lilly and Company Company Details
11.12.2 Eli Lilly and Company Business Overview
11.12.3 Eli Lilly and Company Anorectal Disorders Treatment Introduction
11.12.4 Eli Lilly and Company Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.12.5 Eli Lilly and Company Recent Developments
11.13 Merck
11.13.1 Merck Company Details
11.13.2 Merck Business Overview
11.13.3 Merck Anorectal Disorders Treatment Introduction
11.13.4 Merck Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.13.5 Merck Recent Developments
11.14 Sun Pharmaceutical Industries
11.14.1 Sun Pharmaceutical Industries Company Details
11.14.2 Sun Pharmaceutical Industries Business Overview
11.14.3 Sun Pharmaceutical Industries Anorectal Disorders Treatment Introduction
11.14.4 Sun Pharmaceutical Industries Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.14.5 Sun Pharmaceutical Industries Recent Developments
11.15 NATCO Pharma Limited
11.15.1 NATCO Pharma Limited Company Details
11.15.2 NATCO Pharma Limited Business Overview
11.15.3 NATCO Pharma Limited Anorectal Disorders Treatment Introduction
11.15.4 NATCO Pharma Limited Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.15.5 NATCO Pharma Limited Recent Developments
11.16 LUPIN
11.16.1 LUPIN Company Details
11.16.2 LUPIN Business Overview
11.16.3 LUPIN Anorectal Disorders Treatment Introduction
11.16.4 LUPIN Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.16.5 LUPIN Recent Developments
11.17 Teva Pharmaceutical Industries
11.17.1 Teva Pharmaceutical Industries Company Details
11.17.2 Teva Pharmaceutical Industries Business Overview
11.17.3 Teva Pharmaceutical Industries Anorectal Disorders Treatment Introduction
11.17.4 Teva Pharmaceutical Industries Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.17.5 Teva Pharmaceutical Industries Recent Developments
11.18 Boehringer Ingelheim International
11.18.1 Boehringer Ingelheim International Company Details
11.18.2 Boehringer Ingelheim International Business Overview
11.18.3 Boehringer Ingelheim International Anorectal Disorders Treatment Introduction
11.18.4 Boehringer Ingelheim International Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.18.5 Boehringer Ingelheim International Recent Developments
11.19 AbbVie
11.19.1 AbbVie Company Details
11.19.2 AbbVie Business Overview
11.19.3 AbbVie Anorectal Disorders Treatment Introduction
11.19.4 AbbVie Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.19.5 AbbVie Recent Developments
11.20 Allergan
11.20.1 Allergan Company Details
11.20.2 Allergan Business Overview
11.20.3 Allergan Anorectal Disorders Treatment Introduction
11.20.4 Allergan Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.20.5 Allergan Recent Developments
11.21 Aboott
11.21.1 Aboott Company Details
11.21.2 Aboott Business Overview
11.21.3 Aboott Anorectal Disorders Treatment Introduction
11.21.4 Aboott Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.21.5 Aboott Recent Developments
11.22 Bayer
11.22.1 Bayer Company Details
11.22.2 Bayer Business Overview
11.22.3 Bayer Anorectal Disorders Treatment Introduction
11.22.4 Bayer Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.22.5 Bayer Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の肛門疾患治療市場インサイト及び予測（医薬品、外科手術、その他）(Global Anorectal Disorders Treatment Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の肛門疾患治療市場インサイト及び予測（医薬品、外科手術、その他）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp